Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1381-1386

  Tani, Hideki ^a   Saito, Noboru ^a   Kobayashi, Makio ^a   Kameoka, Shingo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric carcinoma; K sam; Keratinocyte growth factor; Prognosis; Risk factor; Tumor marker

Indexed keywords

K SAM PROTEIN; KERATINOCYTE GROWTH FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STOMACH CANCER;

FEMALE; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; STOMACH NEOPLASMS;

EID: 84876004803     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1397     Document Type: Article

References (24)

1. Yamada A, Saito N, Kameoka S and Kobayashi M: Clinical significance of epidermal growth factor (EGF) expression in gastric cancer. Hepatogastroenterology 54: 1049-1052, 2007.
2. Hirosawa T, Saito N, Kameoka S and Kobayashi M: Clinical significance of epidermal growth factor (EGF) expression for assessing the spreading of human colon cancer. Nippon Daicho Komonbyo Gakkai Zasshi 55: 402-412, 2002.
3. Soyama K, Saito N and Kameoka K: Study on adhesion molecule beta1 integrin in colorectal cancer-quantification of blood levels and immunohistological staining. Nippon Daicho Komonbyo Gakkai Zasshi 52: 119-127, 1999.
4. Suda A, Saito N, Seshimo A, Kameoka S and Kobayashi M: Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer. Int Surg 94: 182-188, 2009.
5. Daiko W, Saito N and Kameoka S: Clinical significance of TGF-beta1 expression in evaluation of the malignancy of colorectal cancer. Nippon Daicho Komonbyo Gakkai Zasshi 58: 377-382, 2005.
6. Hashimoto T, Saito N, Kameoka S, Shibata N and Kobayashi M: Clinical significance of hepatocyte growth factor and its specific receptor c-Met expression in colorectal cancer progression. Acta Histochem Cytochem 37: 139-146, 2004.
7. Saito N, Nishimura H and Kameoka S: Clinical significance of fibronectin expression in colorectal cancer. Mol Med Rep 1: 77-81, 2008.
8. Yashiro M, Chung YS and Sowa M: Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 85: 883-886, 1994.
9. Finch PW and Rubin JS: Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 98: 812-824, 2006.
10. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R and Rusnati M: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178, 2005.
11. Szabo S and Sandor Z: Basic fibroblast growth factor and PDGF in GI diseases. Baillières Clin Gastroenterol 10: 97-112, 1996.
12. Katoh M and Katoh M: FGF signaling network in the gastrointestinal tract (Review). Int J Oncol 29: 163-168, 2006.
13. Nakazawa K, Yashiro M and Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852, 2003.
14. Kunii K, Davis L, Gorenstein J, Hatch H, Yashiro M, Di Bacco A, Elbi C and Lutterbach B: FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res 68: 2340-2348, 2008.
15. Yashiro M, Chung Y, Kubo T, Hato F and Sowa M: Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. J Cancer 74: 1096-1103, 1996.
16. Nakatani H, Tahara E, Yoshida T, Sakamoto H, Suzuki T, Watanabe H, Sekiguchi M, Kaneko Y, Sakurai M, Terada M, et al: Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn J Cancer Res 77: 849-853, 1986.
17. Nakatani H, Sakamoto H, Yoshida T, Yokota J, Tahara E, Sugimura T and Terada M: Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 81: 707-710, 1990.
18. Ishii H, Hattori Y, Itoh H, Kishi T, Yoshida T, Sakamoto H, Oh H, Yoshida S, Sugimura T and Terada M: Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Cancer Res 54: 518-522, 1994.
19. Ishii H, Yoshida T, Oh H, Yoshida S and Terada M: A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol Cell Biol 15: 3664-3671, 1995.
20. Itoh H, Hattori Y, Sakamoto H, Ishii H, Kishi T, Sasaki H, Yoshida T, Koono M, Sugimura T and Terada M: Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Cancer Res 54: 3237-3241, 1994.
21. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
22. Hattori Y, Itoh H, Uchino S, Hosokawa K, Ochiai A, Ino Y, Ishii H, Sakamoto H, Yamaguchi N, Yanagihara K, Hirohashi S, Sugimura T and Terada M: Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 2: 1373-1381, 1996.
23. Toyokawa T, Yashiro M and Hirakawa K: Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma. Oncol Rep 21: 875-880, 2009.
24. Nakamura K, Yashiro M, Matsuoka T, Tendo M, Shimizu T, Miwa A and Hirakawa K: A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer. Gastroenterology 131: 1530-1541, 2006.